Moody’s rates Fresenius Holdings Ba2

Moody’s Investors Service said it assigned a long-term issuer rating of Ba2 to Fresenius Medical Care Holdings, Inc., the sub holding company consolidating all of the U.S. operations of Fresenius Medical Care AG & Co. KGaA.

The outlook is stable.

The rating reflects the company’s standalone credit profile, but also the fact that Fresenius Medical Care Holdings is a material subsidiary of Fresenius Medical Care AG as this entity owns and consolidates all the U.S. operating subsidiaries of the parent, Moody’s explained.

Fresenius Medical Care Holdings accounted for an increased share of revenue and EBITDA of Fresenius Medical Care AG over the last two years, the agency said.

The contribution of this sub holding to the overall group is expected to slightly increase over time, Moody’s added.

The agency also said it that margin pressure in the U.S. dialysis business and strong growth of its margin-dilutive care coordination also are mitigated by improvements in payor mix and costs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.